Interlude Biopharma Co.
2Patents
2Active
2Granted
49Portfolio score
Filing activity: Aug 14, 2020 → Nov 3, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12414979B2 | Compositions and methods for treating Sjogren's syndrome | Human Necessities | 0 | Active |
| US12337024B2 | Larazotide formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.